Showing results (31-40 of 105) with videos related to
Sort By:
Pageof 11
Immunology|July 9, 2002
Effects of C-reactive protein and pentosan polysulphate on human complement activationAndis Klegeris, Edith A Singh, Patrick L McGeerBritish Journal of Pharmacology|June 19, 2003
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptorAndis Klegeris, Christopher J Bissonnette, Patrick L McGeerNeural Regeneration Research|April 17, 2015
A new look at auranofin, dextromethorphan and rosiglitazone for reduction of glia-mediated inflammation in neurodegenerative diseasesJocelyn M Madeira, Stephanie M Schindler, Andis KlegerisJournal of Neuroimmunology|June 28, 2014
Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegenerationLindsay J Spielman, Jonathan P Little, Andis KlegerisBrain Research Bulletin|March 30, 2016
Physical activity and exercise attenuate neuroinflammation in neurological diseasesLindsay Joy Spielman, Jonathan Peter Little, Andis KlegerisNeurochemistry International|August 17, 2018
Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseasesLindsay Joy Spielman, Deanna Lynn Gibson, Andis KlegerisBrain Research Bulletin|January 10, 2019
Extracellular cardiolipin regulates select immune functions of microglia and microglia-like cellsCaitlin B Pointer, Tyler J Wenzel, Andis KlegerisCurrent Opinion in Neurology|May 15, 2007
Therapeutic approaches to inflammation in neurodegenerative diseaseAndis Klegeris, Edith G McGeer, Patrick L McGeerNeurobiology of Aging|February 15, 2005
Modulation of human microglia and THP-1 cell toxicity by cytokines endogenous to the nervous systemAndis Klegeris, Christopher J Bissonnette, Patrick L McGeerNeural Regeneration Research|June 19, 2025
Mitochondrial damage-associated molecular patterns: Neuroimmunomodulators in central nervous system pathophysiologyNoah A H Brooks, Ishvin Riar, Andis KlegerisPageof 11